QBREXZA: payments to doctors
Payments that named QBREXZA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.7M
- Providers
- 6,740
- Transactions
- 16,163
- Average per transaction
- $106
The per-transaction average — $106 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,740 providers the average total is $254, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Dermira, Inc. | $1,564,725 | 91.4% |
| Journey Medical Corporation | $147,233 | 8.6% |